CGI
CLB icon

Comgest Global Investors’s Core Laboratories CLB Stock Holding History

Comgest Global Investors’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-578,635
Closed -$60.4M – 47
2015
Q1 		$60.4M Sell
578,635
-30,951
-5% -$3.3M 1.88% 16
2014
Q4 		$73.4M Buy
+609,586
New +$80.1M 2.24% 15

Other funds holding CLB

ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
WP
Wedgewood Partners St Louis, Missouri $484M AUM 14.59% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
WI
WHV Investments San Francisco, California $187M AUM 14.29% 1-Year Est. Return

Comgest Global Investors's CLB Position: Q2 2015 in Review

Comgest Global Investors sold out of Core Laboratories (CLB) in Q2 2015, closing a stake of 578,635 shares — an estimated $60.4M sold.

Comgest Global Investors first reported a position in CLB in Q4 2014 and held it in 2 quarters. The position peaked at $73.4M in Q4 2014. 356 funds tracked by Wall St. Rank hold CLB as of Q2 2015.

  • Comgest Global Investors reported no remaining Core Laboratories position as of Q2 2015 after selling out during the quarter.
  • Comgest Global Investors sold 578,635 Core Laboratories shares in Q2 2015, an estimated $60.4M.
  • Comgest Global Investors first reported a position in Core Laboratories in Q4 2014 and held it in 2 quarters.
  • Comgest Global Investors's Core Laboratories position peaked at $73.4M in Q4 2014.
  • 356 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2015.

Based on Comgest Global Investors's 13F filing for Q2 2015, filed 28 Jul 2015.